| Paul Michael Greaves, MD | |
|
1046 6th Ave Sw, Albany, OR 97321-1916 | |
| (541) 812-4000 | |
| Not Available |
| Full Name | Paul Michael Greaves |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 30 Years |
| Location | 1046 6th Ave Sw, Albany, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093734584 | NPI | - | NPPES |
| 228863 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | MD19536 (Oregon) | Secondary |
| 207L00000X | Anesthesiology | MD19536 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Samaritan Albany General Hospital | Albany, OR | Hospital |
| Samaritan Lebanon Community Hospital | Lebanon, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Albany General Hospital | 9931097987 | 162 |
| Mid-valley Healthcare Inc | 2769391523 | 134 |
News Archive
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
A woman in southern Ontario is one of the first cases in Canada of a rare neurological syndrome in which a person starts speaking with a different accent, McMaster University researchers report in the July issue of the Canadian Journal of Neurological Sciences.
Sleep apnea is a common disease that affects millions of people all over the world, and if left undiagnosed and untreated can cause serious health complications. GE Sensing & Inspection Technologies has developed the Nova Pressure Amplified (NPA) series of pressure sensors for medical devices. Small and effective, the NPA is a critical component in creating cost-effective sleep apnea monitors that are more accurate and reliable than those currently on the market.
The Food and Drug Administration (FDA) approved Altabax (retapamulin ointment) for topical treatment of impetigo, a skin infection caused by bacteria.
› Verified 2 days ago
| Entity Name | Mid-valley Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689625980 PECOS PAC ID: 2769391523 Enrollment ID: O20031111000297 |
News Archive
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
A woman in southern Ontario is one of the first cases in Canada of a rare neurological syndrome in which a person starts speaking with a different accent, McMaster University researchers report in the July issue of the Canadian Journal of Neurological Sciences.
Sleep apnea is a common disease that affects millions of people all over the world, and if left undiagnosed and untreated can cause serious health complications. GE Sensing & Inspection Technologies has developed the Nova Pressure Amplified (NPA) series of pressure sensors for medical devices. Small and effective, the NPA is a critical component in creating cost-effective sleep apnea monitors that are more accurate and reliable than those currently on the market.
The Food and Drug Administration (FDA) approved Altabax (retapamulin ointment) for topical treatment of impetigo, a skin infection caused by bacteria.
› Verified 2 days ago
| Entity Name | Albany General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154372340 PECOS PAC ID: 9931097987 Enrollment ID: O20040310000310 |
News Archive
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
A woman in southern Ontario is one of the first cases in Canada of a rare neurological syndrome in which a person starts speaking with a different accent, McMaster University researchers report in the July issue of the Canadian Journal of Neurological Sciences.
Sleep apnea is a common disease that affects millions of people all over the world, and if left undiagnosed and untreated can cause serious health complications. GE Sensing & Inspection Technologies has developed the Nova Pressure Amplified (NPA) series of pressure sensors for medical devices. Small and effective, the NPA is a critical component in creating cost-effective sleep apnea monitors that are more accurate and reliable than those currently on the market.
The Food and Drug Administration (FDA) approved Altabax (retapamulin ointment) for topical treatment of impetigo, a skin infection caused by bacteria.
› Verified 2 days ago
| Entity Name | Albany Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710046461 PECOS PAC ID: 1850386616 Enrollment ID: O20040420000244 |
News Archive
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
A woman in southern Ontario is one of the first cases in Canada of a rare neurological syndrome in which a person starts speaking with a different accent, McMaster University researchers report in the July issue of the Canadian Journal of Neurological Sciences.
Sleep apnea is a common disease that affects millions of people all over the world, and if left undiagnosed and untreated can cause serious health complications. GE Sensing & Inspection Technologies has developed the Nova Pressure Amplified (NPA) series of pressure sensors for medical devices. Small and effective, the NPA is a critical component in creating cost-effective sleep apnea monitors that are more accurate and reliable than those currently on the market.
The Food and Drug Administration (FDA) approved Altabax (retapamulin ointment) for topical treatment of impetigo, a skin infection caused by bacteria.
› Verified 2 days ago
| Entity Name | Mid-valley Healthcare Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1689625980 PECOS PAC ID: 2769391523 Enrollment ID: O20061104000140 |
News Archive
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
A woman in southern Ontario is one of the first cases in Canada of a rare neurological syndrome in which a person starts speaking with a different accent, McMaster University researchers report in the July issue of the Canadian Journal of Neurological Sciences.
Sleep apnea is a common disease that affects millions of people all over the world, and if left undiagnosed and untreated can cause serious health complications. GE Sensing & Inspection Technologies has developed the Nova Pressure Amplified (NPA) series of pressure sensors for medical devices. Small and effective, the NPA is a critical component in creating cost-effective sleep apnea monitors that are more accurate and reliable than those currently on the market.
The Food and Drug Administration (FDA) approved Altabax (retapamulin ointment) for topical treatment of impetigo, a skin infection caused by bacteria.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul Michael Greaves, MD Po Box 1188, Corvallis, OR 97339-1188 Ph: () - | Paul Michael Greaves, MD 1046 6th Ave Sw, Albany, OR 97321-1916 Ph: (541) 812-4000 |
News Archive
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
A woman in southern Ontario is one of the first cases in Canada of a rare neurological syndrome in which a person starts speaking with a different accent, McMaster University researchers report in the July issue of the Canadian Journal of Neurological Sciences.
Sleep apnea is a common disease that affects millions of people all over the world, and if left undiagnosed and untreated can cause serious health complications. GE Sensing & Inspection Technologies has developed the Nova Pressure Amplified (NPA) series of pressure sensors for medical devices. Small and effective, the NPA is a critical component in creating cost-effective sleep apnea monitors that are more accurate and reliable than those currently on the market.
The Food and Drug Administration (FDA) approved Altabax (retapamulin ointment) for topical treatment of impetigo, a skin infection caused by bacteria.
› Verified 2 days ago
Dr. Erik Morell, APRN-CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1046 6th Ave Sw, Albany, OR 97321 Phone: 541-812-4000 | |
Alex J Russell, CRNA Anesthesiology Medicare: Medicare Enrolled Practice Location: 1046 6th Ave Sw, Albany, OR 97321 Phone: 541-812-4000 |